PATENT CLAIM ANALYSIS

Application Number: 15962673
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
The present disclosure provides antibodies that specifically bind to human glucocorticoid-induced TNFR family related receptor (GITR) and compositions comprising such antibodies. In a specific aspect, the antibodies specifically bind to human GITR and modulate GITR activity, e.g., enhance, activate or induce GITR activity, utilizing such antibodies. The present disclosure also provides methods for treating disorders, such as cancer and infectious diseases, by administering an antibody that specifically binds to human GITR and modulates GITR activity e.g., enhances, activates or induces GITR activity.

Claim (Index 218):
The isolated nucleic acid molecule of  claim 216 , wherein the antibody comprises:\n (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 567; and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 576.

Metadata:
- Claim Count in Document: 135.0
- Percentile: 91.0
- Lexical Diversity: 1.74545
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14724452', '14472116', '15714585', '11389880', '15517867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7857714075621335
- 35 USC 102 Novelty (BERT): 0.6001384475765913
- Combined Prediction Score: 0.7672081115635793
- Mean Citation Score: 479.718714
- Max Citation Score: 626.9613
- Similarity Product: 444.6053185917378

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test